The hypoxic state at the tumor site induces activation and secretion of semaphorin3A (Sema3A) resulting in recruitment of TAMs via phosphorylation-mediated activation of vascular endothelial growth factor receptor 1 (VEGFR1), which promotes TAMs-mediated angiogenesis and immunosuppression [65]. Here, FLT1 is linked to neoplasm.